Mathieu Kabran
Impact in
-
- Hepatitis C virus research
-
- Hepatitis B Virus Studies
- HIV, Drug Use, Sexual Risk
- Liver Disease Diagnosis and Treatment
- Mycobacterium research and diagnosis
Papers in
-
- Hepatitis B Virus Studies 3
- HIV, Drug Use, Sexual Risk 1
-
- HIV/AIDS drug development and treatment 1
- Tuberculosis Research and Epidemiology 1
- Co-authors
- André Inwoley (4 shared papers)Niklas Luhmann (1 shared paper)Patrick Coffié (1 shared paper)Guillaume Bado (1 shared paper)François Dabis (1 shared paper)Didier Koumavi Ekouévi (1 shared paper)Boris Tchounga (1 shared paper)Serge Eholié (1 shared paper)
- Journals
- Journal of Immunology Research (1 paper)BMC Infectious Diseases (1 paper)International Journal of Drug Policy (1 paper)Journal of Immunological Methods (1 paper)PLoS ONE (1 paper)
- Partner nations
- Ivory CoastFranceBurkina Faso
In The Last Decade
Mathieu Kabran
6 papers receiving 62 citations
Peers
Comparison fields: 5 of 15
- Hepatology 20
- Epidemiology 47
- Infectious Diseases 22
- Virology 3
- Emergency Medicine 3
Countries citing papers authored by Mathieu Kabran
This map shows the geographic impact of Mathieu Kabran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Kabran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Kabran more than expected).
Fields of papers citing papers by Mathieu Kabran
This network shows the impact of papers produced by Mathieu Kabran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Kabran. The network helps show where Mathieu Kabran may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathieu Kabran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 23 | |
| 2 | 2017 | 21 | |
| 3 | 2020 | 9 | |
| 4 | 2014 | 7 | |
| 5 | 2022 | 2 | |
| 6 | 2017 | 1 |
About Mathieu Kabran
Mathieu Kabran is a scholar working on Epidemiology, Infectious Diseases, Molecular Biology, Virology and Hematology, having authored 6 papers that have together received 63 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (3 papers), HIV/AIDS drug development and treatment (1 paper), Tuberculosis Research and Epidemiology (1 paper), HIV Research and Treatment (1 paper), HIV, Drug Use, Sexual Risk (1 paper), vaccines and immunoinformatics approaches (1 paper), Blood groups and transfusion (1 paper) and Biosimilars and Bioanalytical Methods (1 paper). The work is most often cited by research in Hepatology (20 citations), Epidemiology (47 citations), Infectious Diseases (22 citations), Virology (3 citations) and Emergency Medicine (3 citations). Mathieu Kabran has collaborated with scholars based in Ivory Coast, France and Burkina Faso. Frequent co-authors include André Inwoley, Niklas Luhmann, Patrick Coffié, Guillaume Bado, François Dabis, Didier Koumavi Ekouévi, Boris Tchounga, Serge Eholié, Gilles Wandeler and Geoffrey S. Gottlieb. Their work appears in journals such as Journal of Immunology Research, BMC Infectious Diseases, International Journal of Drug Policy, Journal of Immunological Methods and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.